Società Applied Genetic Technologies Corporation
Azioni
AGTC
US03820J1007
Biotecnologia
Attività
Numero di dipendenti: 102
Dirigenti
Dirigenti | Titolo | Età | Da |
---|---|---|---|
David Fellows
CEO | Chief Executive Officer | 67 | 01/11/22 |
David Jacobs
CTO | Chief Tech/Sci/R&D Officer | - | 08/06/22 |
Nadia Waheed
CTO | Chief Tech/Sci/R&D Officer | 47 | 01/12/22 |
Abraham Scaria
CTO | Chief Tech/Sci/R&D Officer | - | 15/11/21 |
Ashwin Datt
BRD | Director/Board Member | - | 01/12/22 |
Chris Hollowood
BRD | Director/Board Member | 50 | 01/12/22 |
Hope D'Oyley-Gay
LAW | General Counsel | - | 11/11/21 |
Gerald Reynolds
TRE | Treasurer | - | 01/03/20 |
Janet Rae
LAW | General Counsel | - | 18/06/21 |
Matthew Feinsod
PRN | Corporate Officer/Principal | - | 01/07/14 |
Amministratori
Amministratori | Titolo | Età | Da |
---|---|---|---|
David Fellows
CEO | Chief Executive Officer | 67 | 01/11/22 |
Chris Hollowood
BRD | Director/Board Member | 50 | 01/12/22 |
Ashwin Datt
BRD | Director/Board Member | - | 01/12/22 |
Classe di azioni
Voto | Quantità | Flottante | Autocontrollo | Flottante totale | |
---|---|---|---|---|---|
Azione A | 1 | 67 686 195 | 67 316 723 ( 99,45 %) | 54 000 ( 0,0798 %) | 99,45 % |
Coordinate società
Beacon Therapeutics (USA), Inc.
14193 NW 119th Terrace Suite 10
32615, Alachua
+386 462 2204
http://agtc.comSettore
Variaz. 1 gen. | Capi. | |
---|---|---|
-2,31% | 103 Mrd | |
+0,56% | 95,28 Mrd | |
+1,69% | 22,15 Mrd | |
-17,37% | 21,02 Mrd | |
-9,30% | 18,15 Mrd | |
-41,01% | 16,73 Mrd | |
-14,85% | 16,05 Mrd | |
+3,21% | 13,68 Mrd | |
+33,54% | 12,17 Mrd |